Sequential topoisomerase I (topo I) and topoisomerase II (topo II) inhibitors in relapsed/refractory aggressive NHL: Results of CALGB 59906, a phase II study of doxorubicin and topotecan.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Smith, SM; Johnson, JL; Niedzwiecki, D; Eder, JP; Canellos, GP; Cheson, BD; Bartlett, NL

Published Date

  • November 16, 2004

Published In

Volume / Issue

  • 104 / 11

Start / End Page

  • 685A - 686A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 46th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • San Diego, CA

Conference Start Date

  • December 4, 2004

Conference End Date

  • December 7, 2004